News
TG Therapeutics will present data on BRIUMVI for relapsing multiple sclerosis at the ACTRIMS forum, February 27 – March 1, 2025. TG Therapeutics, Inc. announced the schedule for presentations on data ...
Kairos Pharma, Ltd. (NYSE American: KAPA), a clinical-stage biopharmaceutical company focused on innovative cancer therapeutics, today announces participation and presentation of initial Phase 1 data ...
– Real-world evidence and clinical studies of TRIKAFTA ® continue to show sustained long-term benefits including improvement in pancreatic function in young patients – BOSTON, September 26, ...
TEL AVIV, Israel and WALTHAM, Mass., Nov. 5, 2024 /PRNewswire/ -- BioLineRx Ltd. (NASDAQ: BLRX) (TASE: BLRX), a commercial stage biopharmaceutical company pursuing life-changing therapies in oncology ...
The National Pharmaceutical Pricing Authority (NPPA) conducted a pre-bid meeting on Tuesday for the tender regarding the ...
Crinetics Pharmaceuticals, Inc. announced that eight abstracts detailing their clinical development programs will be presented at the Endocrine Society's Annual Meeting, ENDO 2025. The presentations ...
PITTSBURGH, Aug. 1, 2025 /PRNewswire/ -- Viatris (Nasdaq: VTRS), a global healthcare company, today announced that five abstracts from its Phase 3 program evaluating novel fast-acting formulation of ...
August 11, 2025 - Previous articles in this series have explored identification, preservation, collection, review and production of novel data sources, but I would be remiss if I left out the last, ...
Want smarter insights in your inbox? Sign up for our weekly newsletters to get only what matters to enterprise AI, data, and security leaders. Subscribe Now Today at Adobe‘s annual digital innovation ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback